PAPER Gezen-Ak D, Dursun E, Bilgiç B, Hanağasi H, Ertan T, Gürvit H, Emre M, Eker E, Ulutin T, Uysal O, Yilmazer S
SEARCH RESULTS
330006 RESULTS
PAPER Abeti R, Duchen MR
Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease.
Neurochem Res. 2012 Nov;37(11):2589-96. PubMed: 23076628PAPER Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M
Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study.
J Neural Transm. 2012 Oct 18; PubMed: 23076723PAPER Bolmont T, Bouwens A, Pache C, Dimitrov M, Berclaz C, Villiger M, Wegenast-Braun BM, Lasser T, Fraering PC
Label-free imaging of cerebral β-amyloidosis with extended-focus optical coherence microscopy.
J Neurosci. 2012 Oct 17;32(42):14548-56. PubMed: 23077040PAPER Prangkio P, Yusko EC, Sept D, Yang J, Mayer M
Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity.
PLoS One. 2012;7(10):e47261. PubMed: 23077580PAPER Kobayashi N, Nagata T, Shinagawa S, Nakayama R, Kondo K, Nakayama K, Yamada H
Association between Neurotrophin-3 Polymorphisms and Executive Function in Japanese Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer Disease.
Dement Geriatr Cogn Disord. 2012;34(3-4):190-7. PubMed: 23075484PAPER Yan JJ, Jung JS, Kim TK, Hasan A, Hong CW, Nam JS, Song DK
Protective effects of ferulic Acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease.
Biol Pharm Bull. 2013 Jan 8;36(1):140-3. PubMed: 23075678PAPER Zhu H, Bhadelia RA, Liu Z, Vu L, Li H, Scott T, Bergathon P, Mwamburi M, Rosenzweig JL, Rosenberg I, Qiu WQ
The Association Between Small Vessel Infarcts and the Activities of Amyloid-β Peptide Degrading Proteases in Apolipoprotein E4 AlleleCarriers.
Angiology. 2012 Oct 23; PubMed: 23076436Rui Peixoto
Harvard Medical SchoolBoston, United States